Chelerythrine is a benzophenanthridine alkaloid.
Application Notes
Chelerythrine Chloride has been shown to inhibit protein kinase C (PKC) by interaction with the PKC catalytic domain. It has also been shown to inhibit PKC translocation from the cytosol to the membrane in isolated ileal synaptosomes.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Inhibits protein kinase C (PKC) by interaction with the PKC catalytic domain | Inhibits PKC translocation from the cytosol to the membrane in isolated ileal synaptosomes
SKU | 0215888805 |
Alternate Names | 1,2-Dimethoxy-N-methyl-[1,3]-benzodioxolo[5,6c]phenanthridinium |
Application Notes | Chelerythrine Chloride has been shown to inhibit protein kinase C (PKC) by interaction with the PKC catalytic domain. It has also been shown to inhibit PKC translocation from the cytosol to the membrane in isolated ileal synaptosomes. |
Base Catalog Number | 15888805 |
Biochemical Physiological Actions | Chelerythrine affects translocation of PKC from cytosol to plasma membrane. Shown to prevent neurite growth. Induces apoptosis in a concentration and schedule-dependent manner. |
CAS # | 3895-92-9 |
EC Number | 223-444-9 |
Hazard Statements | H302-H312-H315-H319-H332-H335 |
Melting Point | 206 - 208 °C(Lit.) |
Molecular Formula | C21H18NO4Cl |
Molecular Weight | 383.8 |
Pack Size | 5 mg |
Purity | ≥98% |
RTECS Number | FL9200000 |
Safety Symbol | GHS07 |
Solubility | Soluble in water (2 mg/mL), methanol (5 mg/mL - clear yellowish solution) and DMSO (4 mg/mL). |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |